349 related articles for article (PubMed ID: 21527578)
1. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.
Jiao L; Taylor PR; Weinstein SJ; Graubard BI; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1430-8. PubMed ID: 21527578
[TBL] [Abstract][Full Text] [Related]
2. Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.
Jiao L; Weinstein SJ; Albanes D; Taylor PR; Graubard BI; Virtamo J; Stolzenberg-Solomon RZ
Cancer Res; 2011 May; 71(10):3582-9. PubMed ID: 21540233
[TBL] [Abstract][Full Text] [Related]
3. Soluble receptor for advanced glycation end products and risk of liver cancer.
Moy KA; Jiao L; Freedman ND; Weinstein SJ; Sinha R; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Hepatology; 2013 Jun; 57(6):2338-45. PubMed ID: 23325627
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.
Chen L; Duan Z; Tinker L; Sangi-Haghpeykar H; Strickler H; Ho GY; Gunter MJ; Rohan T; Logsdon C; White DL; Royse K; El-Serag HB; Jiao L
Cancer Epidemiol; 2016 Jun; 42():115-23. PubMed ID: 27100837
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
6. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
7. The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.
Grote VA; Nieters A; Kaaks R; Tjønneland A; Roswall N; Overvad K; Nielsen MR; Clavel-Chapelon F; Boutron-Ruault MC; Racine A; Teucher B; Lukanova A; Boeing H; Drogan D; Trichopoulou A; Trichopoulos D; Lagiou P; Palli D; Sieri S; Tumino R; Vineis P; Mattiello A; Argüelles Suárez MV; Duell EJ; Sánchez MJ; Dorronsoro M; Huerta Castaño JM; Barricarte A; Jeurnink SM; Peeters PH; Sund M; Ye W; Regner S; Lindkvist B; Khaw KT; Wareham N; Allen NE; Crowe FL; Fedirko V; Jenab M; Romaguera D; Siddiq A; Bueno-de-Mesquita HB; Rohrmann S
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):619-28. PubMed ID: 22301828
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women.
Semba RD; Ferrucci L; Fink JC; Sun K; Beck J; Dalal M; Guralnik JM; Fried LP
Am J Kidney Dis; 2009 Jan; 53(1):51-8. PubMed ID: 18789567
[TBL] [Abstract][Full Text] [Related]
9. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
Basta G; Sironi AM; Lazzerini G; Del Turco S; Buzzigoli E; Casolaro A; Natali A; Ferrannini E; Gastaldelli A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4628-34. PubMed ID: 16926247
[TBL] [Abstract][Full Text] [Related]
10. Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes.
Yu Y; Hanssen KF; Kalyanaraman V; Chirindel A; Jenkins AJ; Nankervis AJ; Torjesen PA; Scholz H; Henriksen T; Lorentzen B; Garg SK; Menard MK; Hammad SM; Scardo JA; Stanley JR; Wu M; Basu A; Aston CE; Lyons TJ
BJOG; 2012 Nov; 119(12):1512-20. PubMed ID: 22900949
[TBL] [Abstract][Full Text] [Related]
11. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.
Semba RD; Ferrucci L; Sun K; Beck J; Dalal M; Varadhan R; Walston J; Guralnik JM; Fried LP
Aging Clin Exp Res; 2009 Apr; 21(2):182-90. PubMed ID: 19448391
[TBL] [Abstract][Full Text] [Related]
13. AGE-RAGE Interaction Does Not Explain the Clinical Improvements after Therapeutic Fasting in Osteoarthritis.
Drinda S; Franke S; Schmidt S; Stoy K; Lehmann T; Wolf G; Neumann T
Complement Med Res; 2018; 25(3):167-172. PubMed ID: 29433120
[TBL] [Abstract][Full Text] [Related]
14. Soluble Receptor for Advanced Glycation End-products (sRAGE) and Colorectal Cancer Risk: A Case-Control Study Nested within a European Prospective Cohort.
Aglago EK; Rinaldi S; Freisling H; Jiao L; Hughes DJ; Fedirko V; Schalkwijk CG; Weiderpass E; Dahm CC; Overvad K; Eriksen AK; Kyrø C; Boutron-Ruault MC; Rothwell JA; Severi G; Katzke V; Kühn T; Schulze MB; Aleksandrova K; Masala G; Krogh V; Panico S; Tumino R; Naccarati A; Bueno-de-Mesquita B; van Gils CH; Sandanger TM; Gram IT; Skeie G; Quirós JR; Jakszyn P; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Johansson I; Harlid S; Perez-Cornago A; Mayén AL; Cordova R; Gunter MJ; Vineis P; Cross AJ; Riboli E; Jenab M
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):182-192. PubMed ID: 33082206
[TBL] [Abstract][Full Text] [Related]
15. Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function.
Kajikawa M; Nakashima A; Fujimura N; Maruhashi T; Iwamoto Y; Iwamoto A; Matsumoto T; Oda N; Hidaka T; Kihara Y; Chayama K; Goto C; Aibara Y; Noma K; Takeuchi M; Matsui T; Yamagishi S; Higashi Y
Diabetes Care; 2015 Jan; 38(1):119-25. PubMed ID: 25336748
[TBL] [Abstract][Full Text] [Related]
16. Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study.
Rebholz CM; Astor BC; Grams ME; Halushka MK; Lazo M; Hoogeveen RC; Ballantyne CM; Coresh J; Selvin E
Nephrol Dial Transplant; 2015 Jan; 30(1):77-83. PubMed ID: 25147225
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.
Bijnen M; van Greevenbroek MMJ; van der Kallen CJH; Scheijen JL; van de Waarenburg MPH; Stehouwer CDA; Wouters K; Schalkwijk CG
J Diabetes Res; 2019; 2019():6289831. PubMed ID: 31218233
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women.
Semba RD; Ferrucci L; Sun K; Patel KV; Guralnik JM; Fried LP
Age Ageing; 2009 May; 38(3):283-9. PubMed ID: 19252206
[TBL] [Abstract][Full Text] [Related]
19. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
[TBL] [Abstract][Full Text] [Related]
20. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
